Systemic sclerosis: an exercise program appears to improve hand and mouth function

An exercise program added to usual care appears to improve hand function, mouth function and quality of life in people with systemic sclerosis. This finding comes from a randomized trial of 46 patients followed for 12 weeks. The available abstract reports statistically significant differences, without providing enough information to assess the practical importance of the improvements.

Illustration of hands and mouth opening, functions assessed in this trial on systemic sclerosis.
TrainingEditorial illustration, not study data.

A program added to usual care

The researchers randomly assigned 46 people with systemic sclerosis to two groups of 23. The intervention group received an exercise program in addition to the standard protocol, while the control group followed the standard protocol.

After an initial interview, the program's video materials were transferred to the phones of participants in the intervention group. However, the abstract does not detail the exercises, their frequency or the length of the sessions. It therefore does not allow the program to be replicated.

Assessments took place at baseline, then at 4, 8 and 12 weeks. They covered hand function, measured using the Duruöz Hand Index, mouth opening and quality of life, assessed using the WHOQOL-BREF questionnaire.

A favorable signal, without a quantified magnitude

At the final follow-up, the authors report statistically significant differences between the groups in hand function, oral function and quality of life, favoring the exercise program.

But the abstract provides neither the scores obtained in each group, nor the magnitude of the differences, nor their confidence intervals. A statistically significant difference is not enough to establish that the change is large enough to be noticeable or useful in everyday life.

The finding concerns a program added to usual care. It does not show that exercises can replace disease management or that they affect the course of the disease.

A conclusion limited to the population studied

Participants had a mean age of 51.7 years and were overwhelmingly women. With this small sample, the findings still need confirmation and cannot automatically be generalized to everyone with systemic sclerosis.

Follow-up ends at 12 weeks in the abstract. Whether the benefits persist beyond that point is therefore not established. Adherence to the program, any adverse effects and the procedures for blinding assessors are not specified in the excerpt reviewed.

Limitations to keep in mind

Only the PubMed abstract was reviewed, not the full text. The sample is small, the population overwhelmingly female and follow-up limited to 12 weeks. The magnitude of the effects, their clinical relevance, tolerability, funding and conflicts of interest cannot be verified from the material provided.

What we can take away

This trial supports the potential value of supplementary exercises for certain everyday functions in systemic sclerosis. It does not yet allow the expected benefit to be quantified or a reproducible program to be proposed.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.